Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Stereotaxis gains CE Mark for MAGiC catheter, boosting revenue with high margins. FDA approval expected soon. Click here to ...
3h
Hosted on MSNBiotechs on the Brink: 2 Stocks With Huge PotentialInvestors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to ...
NEW YORK - OS Therapies, Inc. (NYSE-A: OSTX), a small-cap biotech firm with a market capitalization of $42 million focusing on cancer treatment solutions, has announced the completion of its Phase 2b ...
We view Avita’s RECELL system as a sound alternative treatment for large second- and third-degree burns treated in burn centers. It compares favorably on price and ease of use with new products and ...
Good afternoon, and welcome to the Ultragenyx Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only-mode. At the end of the prepared ...
In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...
Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute ...
Tobacco harm reduction advocates in the Philippines lauded the U.S. Food and Drug Administration’s marketing authorizations ...
Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...
When is a student considered guilty of violating the Medford School District’s cocurricular code regarding drug and tobacco use? A new testing process with the district’s provider raised that question ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results